EUR 16.98
(4.81%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.87 Million EUR | -40.0% |
2022 | 3.12 Million EUR | -28.57% |
2021 | 4.37 Million EUR | -12.97% |
2020 | 5.02 Million EUR | 5863.81% |
2019 | 84.29 Thousand EUR | -43.63% |
2018 | 149.54 Thousand EUR | -30.38% |
2017 | 214.79 Thousand EUR | 0.0% |
2016 | - EUR | 0.0% |
2015 | - EUR | -100.0% |
2014 | 837 Thousand EUR | 0.0% |
2013 | - EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 312.5 Thousand EUR | 0.0% |
2023 FY | 1.87 Million EUR | -40.0% |
2023 Q4 | 1.87 Million EUR | 0.0% |
2023 Q2 | 2.5 Million EUR | 0.0% |
2022 Q4 | 3.12 Million EUR | 0.0% |
2022 Q2 | 3.75 Million EUR | 0.0% |
2022 FY | 3.12 Million EUR | -28.57% |
2021 Q4 | 4.37 Million EUR | 0.0% |
2021 FY | 4.37 Million EUR | -12.97% |
2021 Q2 | 5 Million EUR | 0.0% |
2020 FY | 5.02 Million EUR | 5863.81% |
2020 Q2 | 5.05 Million EUR | 0.0% |
2020 Q4 | 5.02 Million EUR | 0.0% |
2019 FY | 84.29 Thousand EUR | -43.63% |
2019 Q2 | 117.55 Thousand EUR | 0.0% |
2019 Q4 | 84.29 Thousand EUR | 0.0% |
2018 Q2 | 182.17 Thousand EUR | 0.0% |
2018 Q4 | 149.54 Thousand EUR | 0.0% |
2018 FY | 149.54 Thousand EUR | -30.38% |
2017 Q2 | - EUR | 0.0% |
2017 Q4 | 214.79 Thousand EUR | 0.0% |
2017 FY | 214.79 Thousand EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2016 FY | - EUR | 0.0% |
2016 Q2 | - EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2015 FY | - EUR | -100.0% |
2015 Q2 | 14.38 Thousand EUR | 0.0% |
2014 FY | 837 Thousand EUR | 0.0% |
2013 FY | - EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 10.48 Billion EUR | 99.982% |
Fresenius SE & Co. KGaA | 13.24 Billion EUR | 99.986% |
LIMES Schlosskliniken AG | 10.09 Million EUR | 81.417% |
Maternus-Kliniken Aktiengesellschaft | 53.96 Million EUR | 96.525% |
MEDICLIN Aktiengesellschaft | 66.41 Million EUR | 97.177% |
RHÖN-KLINIKUM Aktiengesellschaft | 141.77 Million EUR | 98.677% |
VITA 34 AG | 3.38 Million EUR | 44.641% |